Skip to main content Accessibility help


  • Siok Swan Tan (a1), Clazien A. M. Bouwmans (a2), Frans F. H. Rutten (a2) and Leona Hakkaart-van Roijen (a2)


Objectives: In 2000, the first “Dutch Manual for Costing: Methods and Reference Prices for Economic Evaluations in Healthcare” was published, followed by an updated version in 2004. The purpose of the Manual is to facilitate the implementation and assessment of costing studies in economic evaluations. New developments necessitated the publication of a thoroughly updated version of the Manual in 2010. The present study aims to describe the main changes of the 2010 Manual compared with earlier editions of the Manual.

Methods: New and updated topics of the Manual were identified. The recommendations of the Manual were compared with the health economic guidelines of other countries, eliciting strengths and limitations of alternative methods.

Results: New topics in the Manual concern medical costs in life-years gained, the database of the Diagnosis Treatment Combination (DBC) casemix System, reference prices for the mental healthcare sector and the costs borne by informal care-givers. Updated topics relate to the friction cost method, discounting future effects and options for transferring cost results from international studies to the Dutch situation.

Conclusions: The Action Plan is quite similar to many health economic guidelines in healthcare. However, the recommendations on particular aspects may differ between national guidelines in some respects. Although the Manual may serve as an example to countries intending to develop a manual of this kind, it should always be kept in mind that preferred methods predominantly depend on a country's specific context.



Hide All
1.Barbieri, M, Drummond, M, Willke, R, et al. . Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: Lessons for inferring generalizability. Value Health. 2005;8:1023.
2.Brouwer, WB, Niessen, LW, Postma, MJ, Rutten, FF. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331:446448.
3.Centraal Administratie Kantoor. Jaarverslag 2008. CAK: Den Haag; Juni 2009.
4.Claxton, K, Paulden, M, Gravelle, H, Brouwer, W, Culyer, AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20:215.
5.Commonwealth of Australia. Manual of recourse items and their associated costs 2009. 4th ed.Canberra: Commonwealth of Australia; 2009.
6.Curtis, L. Unit costs of health and social care 2010. 18th ed.Canterbury: University of Kent; 2010.
7.Ferguson, B. NHS database of reference costs is severely flawed. BMJ. 2001;323:106.
8.Goldstein, H. Multilevel statistical models. 3rd ed.New York: Oxford University Press; 2003.
9.Hakkaart–van Roijen, L, Tan, SS, Bouwmans-Frijters, CAM. Handleiding voor kostenonderzoek: Methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg, geactualiseerde versie 2010.
10.Hjelmgren, J, Berggren, F, Andersson, F. Health economic guidelines–similarities, differences and some implications. Value Health. 2001;4:225250.
11.Hoffmann, C, Graf von der Schulenburg, JM. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy. 2000;52:179192.
12.Johnston, K, Buxton, MJ, Jones, DR, Fitzpatrick, R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3:176.
13.Koopmanschap, MA, Rutten, FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10:460466.
14.Krauth, C, Hessel, F, Hansmeier, T, et al. . [Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation]. Gesundheitswesen. 2005;67:736746.
15.Oostenbrink, JB, Koopmanschap, MA, Rutten, FF. Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics. 2002;20:443454.
16.Raftery, J, Roderick, P, Stevens, A. Potential use of routine databases in health technology assessment. Health Technol Assess. 2005;9:192, iii-iv.
17.Raikou, M, Briggs, A, Gray, A, McGuire, A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ. 2000;9:191198.
18.Rappange, DR, van Baal, PH, van Exel, NJ, et al. . Unrelated medical costs in life-years gained: Should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics. 2008;26:815830.
19.Rodenburg-van Dieten HEM. Richtlijnen voor Farmaco-Economisch Onderzoek; Evaluatie en Actualisatie. Diemen: College voor zorgverzekeringen; 2005.
20.Rutten-van Molken, M. Van kosten tot effecten: Een handleiding voor evaluatiestudies in de gezondheidszorg. 2nd ed.Maarssen: Elsevier gezondheidszorg; 2010.
21.Swindle, R, Lukas, CV, Meyer, DA, Barnett, PG, Hendricks, AM. Cost analysis in the Department of Veterans Affairs: Consensus and future directions. Med Care. 1999;37:AS3AS8.
22.Tan, SS. Microcosting in economic evaluations: Issues of accuracy, feasibility, consistency and generalisability.,%20Siok%20Swan.pdf. 1st ed. Rotterdam: Erasmus Universiteit Rotterdam; 2009.
23.Tan, SS, van Ineveld, BM, Redekop, WK, Hakkaart-van Roijen, L. The Netherlands: The diagnose behandeling combinaties (DBCs). In: Busse, R, Geissler, A, Quentin, W, Wiley, MM, eds. Diagnosis-related groups in Europe: Moving towards transparency, efficiency and quality in hospitals, 1st ed.Buckingham: Open University Press and WHO Regional Office for Europe; 2011.
24.Tan, SS, Rutten, FF, van Ineveld, BM, Redekop, WK, Hakkaart-van Roijen, L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10:3945.
25.van Baal, P, Brouwer, W. PAID 1.0 in practice: A brief clarification regarding its possibilities and limitations. Pharmacoeconomics. 2011;29:545547.
26.van den Hout, WB. The value of productivity: Human-capital versus friction-cost method. Ann Rheum Dis. 2010;69 (Suppl 1):i89i91.
27.Weinstein, MC, O'Brien, B, Hornberger, J, et al. . Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health. 2003;6:917.
28.Wordsworth, S, Ludbrook, A, Caskey, F, Macleod, A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ. 2005;6:3844.



  • Siok Swan Tan (a1), Clazien A. M. Bouwmans (a2), Frans F. H. Rutten (a2) and Leona Hakkaart-van Roijen (a2)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed